151 related articles for article (PubMed ID: 11882029)
21. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
23. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.
Pellegrini A; Carrera-Silva EA; Arocena A; Cano RC; Aoki MP; Gea S
Med Microbiol Immunol; 2011 Nov; 200(4):209-18. PubMed ID: 21431877
[TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease.
Grauert MR; Houdayer M; Hontebeyrie-Joskowciz M
Clin Exp Immunol; 1993 Jul; 93(1):85-92. PubMed ID: 7686828
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
Galvão da Silva AP; de Almeida Abrahamsohn I
Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
[TBL] [Abstract][Full Text] [Related]
26. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
27. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.
Wizel B; Palmieri M; Mendoza C; Arana B; Sidney J; Sette A; Tarleton R
J Clin Invest; 1998 Sep; 102(5):1062-71. PubMed ID: 9727076
[TBL] [Abstract][Full Text] [Related]
28. Trypanosoma cruzi: infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity.
Velge P; Kusnierz JP; Ouaissi A; Marty B; Pham BN; Capron A
Eur J Immunol; 1991 Sep; 21(9):2145-52. PubMed ID: 1909643
[TBL] [Abstract][Full Text] [Related]
29. Very large and isotypically atypical polyclonal plaque-forming cell responses in mice infected with Trypanosoma cruzi.
D'Imperio Lima MR; Joskowicz M; Coutinho A; Kipnis T; Eisen H
Eur J Immunol; 1985 Feb; 15(2):201-3. PubMed ID: 3918873
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
Kierszenbaum F; Lopez HM; Sztein MB
Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
[TBL] [Abstract][Full Text] [Related]
31. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
[TBL] [Abstract][Full Text] [Related]
32. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
Van Voorhis WC
J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
[TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi glycoprotein of M(r) 56,000 characterization and assessment of its potential to protect against fatal parasite infections.
Harth G; Mills AA; Lin T; Araujo FG
Mol Microbiol; 1994 Jan; 11(2):261-71. PubMed ID: 8170388
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
Kierszenbaum F; Moretti E; Sztein MB
Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
[TBL] [Abstract][Full Text] [Related]
35. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
36. Specific activation of CD4
Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses.
Rizzo LV; Cunha-Neto E; Teixeira AR
Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():360-2. PubMed ID: 3150998
[No Abstract] [Full Text] [Related]
38. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.
Bermejo DA; Amezcua-Vesely MC; Montes CL; Merino MC; Gehrau RC; Cejas H; Acosta-Rodríguez EV; Gruppi A
PLoS Negl Trop Dis; 2010 May; 4(5):e679. PubMed ID: 20454564
[TBL] [Abstract][Full Text] [Related]
39. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein.
Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC
Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244
[TBL] [Abstract][Full Text] [Related]
40. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
Miller MJ; Wrightsman RA; Stryker GA; Manning JE
J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
